A critical breakthrough in cancer research is occurring with the use of VHH fragments to reactivate dysfunctional p53. This vital tumor inhibitor protein is frequently disabled in various forms of malignancies, https://health-lists.com/story22797456/mini-antibodies-reactivate-the-p53-protein-new-potential-approach-for-malignant-management